Commonly used serum tumor markers, including carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA 19-9), detect only about 40% of recurrences9 with poor sensitivity and specificity10. This evidence concerns the gene CEACAM5 and neoplasm.